Monday, June 11, 2018 4:10:50 PM
Recent VKTX News
- Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 • PR Newswire (US) • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 11:31:16 AM
- Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024 • PR Newswire (US) • 11/04/2024 11:30:00 AM
- Tesla Sales Drop; Intel to Exit Dow Jones After 25 Years; VKTX and ATSG Surge Over 20% Pre-Market • IH Market News • 11/04/2024 11:20:51 AM
- Viking Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 10/31/2024 08:05:00 PM
- Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024 • PR Newswire (US) • 10/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2024 11:28:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/25/2024 08:10:16 PM
- Tesla Shares Rise 11% Pre-Market; IBM Falls 4% on Lower-Than-Expected Revenue; Apple Prepares New Launches • IH Market News • 10/24/2024 10:07:47 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/23/2024 09:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 08:09:55 PM
- Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 10/23/2024 08:05:00 PM
- US Futures Fall Amid Treasury Yield Surge and Earnings; Oil Prices Dip as U.S. Crude Inventories Rise • IH Market News • 10/23/2024 09:58:27 AM
- Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024 • PR Newswire (US) • 10/16/2024 08:05:00 PM
- Tesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue Forecast • IH Market News • 10/10/2024 10:45:48 AM
- Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD • PR Newswire (US) • 10/09/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2024 01:20:57 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/20/2024 08:29:51 PM
- Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference • PR Newswire (US) • 08/28/2024 08:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 11:23:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 08:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:13:31 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/20/2024 12:00:06 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM